《先前无症状心肌梗死对急性心肌梗死患者预后的意义》

  • 来源专题:心血管疾病防治
  • 编译者: 张燕舞
  • 发布时间:2018-05-22
  • 为了调查首次急性心肌梗死(AMI)患者中无症状心肌梗塞(MI)的患病率,以及其与长期随访中死亡率和主要不良心血管事件(MACE)的关系。在近400例心肌梗塞(MI)患者中,进行了晚期钆增强(LGE)的心脏磁共振成像(CMR),并且超过8%的人群显示先前无症状的MI。 这些患者的死亡率和主要不良心脏事件风险随后增加3-4倍。 因此,在患有临床MI的患者中,通过CMR与LGE鉴定沉默MI具有重要的预后意义,并且应该对这些患者进行积极的管理。

    OBJECTIVES:This study investigated the prevalence of silent myocardial infarction (MI) in patients presenting with first acute myocardial infarction (AMI), and its relation with mortality and major adverse cardiovascular events (MACE) at long-term follow-up.

    BACKGROUND:Up to 54% of MI occurs without apparent symptoms. The prevalence and long-term prognostic implications of previous silent MI in patients presenting with seemingly first AMI are unclear.

    METHODS:A 2-center observational longitudinal study was performed in 392 patients presenting with first AMI between 2003 and 2013, who underwent late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) examination within 14 days post-AMI. Silent MI was assessed on LGE-CMR images by identifying regions of hyperenhancement with an ischemic distribution pattern in other territories than the AMI. Mortality and MACE (all-cause death, reinfarction, coronary artery bypass grafting, and ischemic stroke) were assessed at 6.8 ± 2.9 years follow-up.

    RESULTS:Thirty-two patients (8.2%) showed silent MI on LGE-CMR. Compared with patients without silent MI, mortality risk was higher in patients with silent MI (hazard ratio: 3.87; 95% confidence interval: 1.21 to 12.38; p = 0.023), as was risk of MACE (hazard ratio: 3.10; 95% confidence interval: 1.22 to 7.86; p = 0.017), both independent from clinical and infarction-related characteristics.

    CONCLUSIONS:Silent MI occurred in 8.2% of patients presenting with first AMI and was independently related to poorer long-term clinical outcome, with a more than 3-fold risk of mortality and MACE. Silent MI holds prognostic value over important traditional prognosticators in the setting of AMI, indicating that these patients represent a high-risk subgroup warranting clinical awareness.

  • 原文来源:http://imaging.onlinejacc.org/content/early/2018/04/13/j.jcmg.2018.02.009
相关报告
  • 《2型糖尿病和急性心肌梗死的患者心血管事件的因素》

    • 来源专题:重大新药创制—内分泌代谢
    • 编译者:李永洁2
    • 发布时间:2015-11-30
    • 降低心血管风险依然是2型糖尿病患者生存的一个挑战。本研究的目的是评估人口,血糖,以及其他临床因素和高血糖心血管(CV)风险影响后急性心肌梗死患者心血管预后的2型糖尿病患者。无心血管事件是主要终点。餐后2小时血糖的变化与此有关。在平均随访时间73.48周期间,餐后血糖的改变≤-0.14毫摩尔/升,其间无心血管事件的生存率达到75%。糖化血红蛋白水平≤-0.92%(-10.06毫摩尔/摩尔)和没有中风或急性心肌梗死病史的。空腹血糖和随机胰岛素治疗策略是无事件生存率弱预测因素。餐后血糖应被视为一个潜在的目标在试验中,以减少心血管事件在2型糖尿病的发病率和死亡率。
  • 《肺超声评价ST段抬高心肌梗死亚临床充血》

    • 来源专题:重大疾病防治
    • 编译者:蒋君
    • 发布时间:2023-06-05
    • 目的 评价肺超声(LUS)对ST段抬高型心肌梗死(STEMI)患者亚临床充血的预后价值。 方法 这是一项多中心研究,前瞻性地纳入了312名入院时无心力衰竭(HF)征兆的STEMI患者。在血管重建后的头24小时内进行LUS检查,并将患者分为湿肺(至少一个肺野有三条或更多的B线)或干燥肺。主要终点是急性心衰、心源性休克或住院期间死亡。次要终点是30天随访期间因心力衰竭或新的急性冠脉综合征或死亡而再次入院的综合指标。在所有患者中计算Zwolle评分,通过将LUS的结果与该评分相加来评估预测性改善。 结果 湿肺组有14例(31.1%)出现主要终点,而干肺组有7例(2.6%)出现主要终点。次要终点发生在湿肺组5例(11.6%)和干肺组3例(1.2%)。LU的加入提高了Zwolle评分预测后续复合终点的能力(净重分类改善0.99)。LUS对住院和随访终点的预测具有很高的阴性预测值(分别为97.4%和98.9%)。 结论 入院时LUS诊断的Killip I STEMI患者早期亚临床肺充血与住院期间和30天随访的不良结局有关。